Amendments for: 172-2022-2023-Q3-997002

Current (Nov 30, 2023)
Agreement Value: $699,000.00
Agreement: Neuromuscular junction-on-a-chip for rapid diagnosis of neuromuscular diseases and applications in precision medicine (997002). Sep 26, 2022 - Mar 14, 2024
Description:

Neuromuscular diseases (NMDs) affect approximately 13 million worldwide, there is no cure and no effective therapy. There is a major need for robust, scalable, and reproducible in vitro models of human neuromuscular junctions (NMJ) to test therapeutic candidates. Ananda Devices, guided by the needs from the top pharmaceutical company in this market, developed a first-in-class, patent protected technology that enables the establishment of a highly standardized human NMJ in vitro. In this project, we scale up this platform with high reproducibility and quality.

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Organization: National Research Council Canada
Recipient: Ananda Devices Inc. (For-profit organization)
Location: Montreal, Quebec, CA H4R 3E9
Type: Contribution
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days.

Recipient's Operating Name: ANANDA Devices
Federal Riding Name: Saint-Laurent (24068)
Program Name: Industrial Research Assistance Program – Contributions to Firms

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Coverage: IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code: 54199
Amendment 02 (Nov 30, 2023)
Agreement Value:
Organization: National Research Council Canada
Recipient: -
Type: -
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 90 days.

Amendment 01 (May 10, 2023)
Agreement Value: $699,000.00
Organization: National Research Council Canada
Recipient: Ananda Devices Inc.
Type: -
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 198 days. The total amended value is 414,000 dollars.

Amendment 00 (Dec 16, 2022)
Agreement Value: $285,000.00
Agreement: Neuromuscular junction-on-a-chip for rapid diagnosis of neuromuscular diseases and applications in precision medicine (997002). Sep 26, 2022 - May 31, 2023
Description:

Neuromuscular diseases (NMDs) affect approximately 13 million worldwide, there is no cure and no effective therapy. There is a major need for robust, scalable, and reproducible in vitro models of human neuromuscular junctions (NMJ) to test therapeutic candidates. Ananda Devices, guided by the needs from the top pharmaceutical company in this market, developed a first-in-class, patent protected technology that enables the establishment of a highly standardized human NMJ in vitro. In this project, we scale up this platform with high reproducibility and quality.

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Organization: National Research Council Canada
Recipient: 9493662 CANADA Inc (For-profit organization)
Location: Montreal, Quebec, CA H4R 3E9
Type: Contribution
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days. The total amended value is 285,000 dollars.

Recipient's Operating Name: ANANDA Devices
Federal Riding Name: Saint-Laurent (24068)
Program Name: Industrial Research Assistance Program – Contributions to Firms

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Coverage: IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code: 54199